UT Health San Antonio | The University of Texas Health Science Center at San Antonio
Category ID
46

KENS 5: Student athletes encouraged to get preventative dental screenings ahead of new school year

Scott Stafford, DDS, MBA, clinical assistant professor and interim chair of the Department of Comprehensive Dentistry, was interviewed for this news segment.   Watch Now

Share This Story

Medical Xpress: Drug shows promise for treating brain tumors resulting from breast cancer, trial reports

Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article.   Read More

Share This Story

Science Magazine: Drug shows promise for treating brain tumors resulting from breast cancer, UT Health San Antonio trial reports

Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article.   Read More

Share This Story

Mirage News — UT Health SA: Drug Shows Promise for Breast Cancer Brain Tumors

Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article.   Read More

Share This Story

AHRQ: Identifying and Disseminating Best Practices To Treat Long COVID

Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Physical Medicine and Rehabilitation, and director of its long COVID clinics, was featured in this story.   Read More

Share This Story

Yahoo! Finance: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

Share This Story

MSN.com: UT Health San Antonio study: HIV drug may be effective against Alzheimer’s disease

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

Share This Story

For Worth Star-Telegram: UT Health San Antonio study — HIV drug may be effective against Alzheimer’s disease

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

Share This Story

Clinical Trials Arena: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s

A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article.   Read More

Share This Story

WOAI-TV: Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials

This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment.   Watch Now

Share This Story

Subscribe to In the News